SA, R., X, Z., SP, K., P, M., M, H., MB, B., . . . SE, M. (2023). Novel Strategy to Combat the Procoagulant Phenotype in Heparin-Induced Thrombocytopenia Using 12-LOX Inhibition. Arteriosclerosis, thrombosis, and vascular biology, 43(10), 1808. https://doi.org/10.1161/ATVBAHA.123.319434
Chicago Style (17th ed.) CitationSA, Renna, Zhao X, Kunapuli SP, Ma P, Holinstat M, Boxer MB, Maloney DJ, Michael JV, and McKenzie SE. "Novel Strategy to Combat the Procoagulant Phenotype in Heparin-Induced Thrombocytopenia Using 12-LOX Inhibition." Arteriosclerosis, Thrombosis, and Vascular Biology 43, no. 10 (2023): 1808. https://doi.org/10.1161/ATVBAHA.123.319434.
MLA (9th ed.) CitationSA, Renna, et al. "Novel Strategy to Combat the Procoagulant Phenotype in Heparin-Induced Thrombocytopenia Using 12-LOX Inhibition." Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 43, no. 10, 2023, p. 1808, https://doi.org/10.1161/ATVBAHA.123.319434.